ArticlePloS one2021

Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.

J E Meca-Lallana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.